I Šimková, R Aiglová, F Koubek, J Přeček, J Látal, E Buriánková, L Quinn, L Henzlová, M Táborský, H Švébišová, L Tučková, B Melichar
BACKGROUND: The survival of patients with neuroendocrine tumors has substantially improved with modern treatment options. Although the associated carcinoid syndrome can be diagnosed early and controlled effectively, cardiologists still encounter patients with cardiac manifestations, particularly among individuals with persistently high levels of vasoactive mediators. Treatment options have been limited to surgical valve replacement in fully manifested disease. Since surgery is not always feasible, transcatheter valve implantation is becoming an interesting alternative...
2024: Klinická Onkologie: Casopis Ceské a Slovenské Onkologické Spolecnosti